Reported Standalone quarterly numbers for Panacea Biotec are:
Net Sales at Rs 79.86 crore in March 2021 up 40.67% from Rs. 56.77 crore in March 2020.
Story continues below Advertisement
Quarterly Net Loss at Rs. 18.31 crore in March 2021 up 43.63% from Rs. 32.48 crore in March 2020.
EBITDA stands negative at Rs. 8.36 crore in March 2021 down 583.24% from Rs. 1.73 crore in March 2020.
Panacea Biotec shares closed at 415.30 on June 02, 2021 (BSE)
Story continues below Advertisement
| Panacea Biotec | | Standalone Quarterly Results | in Rs. Cr. |
|
| Mar'21 | Dec'20 | Mar'20 | | Net Sales/Income from operations | 79.86 | 69.02 | 56.77 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 79.86 | 69.02 | 56.77 | | EXPENDITURE | | Consumption of Raw Materials | 7.12 | 24.82 | 22.71 | | Purchase of Traded Goods | 12.00 | 15.10 | 11.44 | | Increase/Decrease in Stocks | 20.06 | -12.64 | -6.93 | | Power & Fuel | -- | -- | -- | | Employees Cost | 17.73 | 14.67 | 12.94 | | Depreciation | 6.57 | 6.64 | 6.57 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 39.06 | 23.80 | 42.68 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | -22.68 | -3.37 | -32.64 | | Other Income | 7.75 | 7.17 | 27.80 | | P/L Before Int., Excpt. Items & Tax | -14.93 | 3.80 | -4.84 | | Interest | 1.86 | 1.89 | 1.78 | | P/L Before Exceptional Items & Tax | -16.79 | 1.91 | -6.62 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | -16.79 | 1.91 | -6.62 | | Tax | 1.52 | 0.01 | 9.83 | | P/L After Tax from Ordinary Activities | -18.31 | 1.90 | -16.45 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -16.03 | | Net Profit/(Loss) For the Period | -18.31 | 1.90 | -32.48 | | Equity Share Capital | 6.13 | 6.13 | 6.13 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -2.99 | 0.31 | -2.69 | | Diluted EPS | -2.99 | 0.31 | -2.69 | | EPS After Extra Ordinary | | Basic EPS | -2.99 | 0.31 | -2.69 | | Diluted EPS | -2.99 | 0.31 | -2.69 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
